Morgan Stanley Gsk PLC Transaction History

Morgan Stanley

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Oct 27, 2022	BUY	$42.05 - $47.77 $151 Million - $171 Million	3,586,797 Added 85.1%	7,801,625 $340 Million
Q2 2022 Aug 15, 2022	BUY	$42.05 - $47.77 $151 Million - $171 Million	3,586,797 Added 85.1%	7,801,625 $340 Million
Q1 2022 Oct 27, 2022	SELL	$40.23 - $47.74 $144 Million - $171 Million	-3,586,797 Reduced 45.97%	4,214,828 $184 Million
Q1 2022 May 13, 2022	SELL	$40.23 - $47.74 $3.86 Million - $4.58 Million	-95,997 Reduced 2.23%	4,214,828 $184 Million
Q4 2021 Feb 14, 2022	BUY	$38.88 - $45.31 $1.89 Million - $2.2 Million	48,548 Added 1.14%	4,310,825 $190 Million
Q3 2021 Nov 15, 2021	BUY	$38.79 - $43.16 $165 Million - $184 Million	4,262,277 New	4,262,277 $163 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.